- $4.04bn
- $3.95bn
- $3.66bn
Annual income statement for Myr, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,498 | 3,009 | 3,644 | 3,362 | 3,658 |
| Cost of Revenue | |||||
| Gross Profit | 325 | 344 | 364 | 290 | 424 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,380 | 2,894 | 3,515 | 3,308 | 3,491 |
| Operating Profit | 119 | 115 | 129 | 54.1 | 167 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 116 | 114 | 125 | 46.5 | 161 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 85 | 83.4 | 91 | 30.3 | 118 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 85 | 83.4 | 91 | 30.3 | 118 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 85 | 83.4 | 91 | 30.3 | 118 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.82 | 4.81 | 5.22 | 1.56 | 7.33 |